{
  "name": "Metformin",
  "category": "pharmaceutical",
  "mechanisms": [
    "AMPK activation",
    "mTOR inhibition",
    "Glucose regulation"
  ],
  "evidenceGrade": "B",
  "riskProfile": "low",
  "dosage": {
    "standard": "500-1000mg/day",
    "range": "500-2000mg/day",
    "notes": "Start low, increase gradually. May deplete B12."
  },
  "keyFindings": [
    "TAME trial ongoing — largest anti-aging drug trial",
    "Diabetics on metformin live longer than non-diabetic controls",
    "May blunt exercise benefits — timing matters"
  ],
  "contraindications": [
    "Kidney disease (eGFR <30)",
    "Active alcoholism",
    "Severe liver disease"
  ],
  "tags": [
    "ampk",
    "glucose",
    "prescription",
    "tame-trial"
  ],
  "id": "prod-metformin",
  "description": "TAME trial ongoing — largest anti-aging drug trial",
  "interactions": [],
  "sideEffects": [],
  "sources": [],
  "suppliers": [],
  "communityReports": [],
  "expertOpinions": [],
  "lastUpdated": "2026-02-04T08:33:44.506Z",
  "createdAt": "2026-02-04T08:33:44.506Z"
}